TD Cowen Reaffirms “Hold” Rating for Enhabit (NYSE:EHAB)

Enhabit (NYSE:EHAB)‘s stock had its “hold” rating reaffirmed by analysts at TD Cowen in a report released on Friday. They presently have a $13.80 price objective on the stock. TD Cowen’s price target points to a potential upside of 1.40% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enhabit in a research report on Monday, December 29th. Leerink Partners boosted their price objective on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a research note on Monday, February 23rd. UBS Group restated a “neutral” rating and set a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Tuesday, February 24th. Jefferies Financial Group downgraded Enhabit from a “buy” rating to a “hold” rating and lifted their price target for the company from $12.50 to $13.80 in a report on Monday, February 23rd. Finally, Truist Financial set a $13.80 price objective on Enhabit in a research note on Monday, February 23rd. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $13.57.

Enhabit Price Performance

Shares of EHAB stock opened at $13.61 on Friday. Enhabit has a twelve month low of $6.47 and a twelve month high of $13.64. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.75. The stock has a fifty day simple moving average of $11.05 and a two-hundred day simple moving average of $9.33. The stock has a market capitalization of $688.76 million, a price-to-earnings ratio of -151.22 and a beta of 1.56.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. Enhabit had a positive return on equity of 4.67% and a negative net margin of 0.43%.The firm had revenue of $270.40 million during the quarter, compared to the consensus estimate of $270.56 million. On average, analysts predict that Enhabit will post 0.22 EPS for the current fiscal year.

Institutional Trading of Enhabit

Several large investors have recently bought and sold shares of the stock. Osaic Holdings Inc. boosted its stake in shares of Enhabit by 337.5% in the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock worth $25,000 after buying an additional 2,018 shares during the last quarter. State of Alaska Department of Revenue acquired a new position in Enhabit in the third quarter valued at approximately $27,000. Tower Research Capital LLC TRC boosted its position in Enhabit by 82.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock worth $44,000 after purchasing an additional 2,059 shares in the last quarter. Russell Investments Group Ltd. boosted its position in Enhabit by 523.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock worth $56,000 after purchasing an additional 4,865 shares in the last quarter. Finally, Simplex Trading LLC grew its stake in shares of Enhabit by 69.8% during the 4th quarter. Simplex Trading LLC now owns 8,115 shares of the company’s stock worth $75,000 after purchasing an additional 3,336 shares during the period.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.